Search Videos

UK Specialist Discusses New, Oral Medicines for CLL
91 views | Added Jan 30, 2013 | Rate View top rated
Share this story
Email
Embed
New, targeted oral medicines promise to revolutionize the treatment of chronic lymphocytic leukemia, CLL. A leading specialist from London, Dr. Claire Dearden, is excited about the latest data that Ibrutinib is highly effective for many patients and that other oral medicines also show promise. In this interview she also comments on clinical trials for patients in the UK.
View more stories like this
Be the first to comment. Please sign in to add your thoughts below.
Related Videos
This collection is currently empty.